Cargando…
A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers
Recent progress in epigenetic research has made a profound influence on pharmacoepigenomics, one of the fastest growing disciplines promising to provide new epi-drugs for the treatment of a broad range of diseases. Histone acetylation is among the most essential chromatin modifications underlying th...
Autores principales: | Shin, Dong-Guk, Bayarsaihan, Dashzeveg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369046/ https://www.ncbi.nlm.nih.gov/pubmed/28356894 |
Ejemplares similares
-
Deciphering the Epigenetic Code in Embryonic and Dental Pulp Stem Cells
por: Bayarsaihan, Dashzeveg
Publicado: (2016) -
Diversity and Complexity in Chromatin Recognition by TFII-I Transcription Factors in Pluripotent Embryonic Stem Cells and Embryonic Tissues
por: Makeyev, Aleksandr V., et al.
Publicado: (2012) -
Single-Cell Transcriptome Analysis Defines Expression of Kabuki Syndrome-Associated KMT2D Targets and Interacting Partners
por: Enkhmandakh, Badam, et al.
Publicado: (2022) -
The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies
por: Huntly, Brian
Publicado: (2013) -
Inhibition of the BET family of epigenetic reader proteins: A novel principle for modulating gene expression in IgE‐activated mast cells
por: Garcia‐Faroldi, Gianni, et al.
Publicado: (2017)